AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nuvectis Pharma, Inc. Director's Dealing 2025

May 9, 2025

Director's Dealing

Opens in your device viewer

Issuer: Nuvectis Pharma, Inc. (NVCT)
CIK: 0001875558
Period of Report: 2025-05-06

Reporting Person: Mosseri Marlio Charles (10% Owner)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-06	Common Stock	P	2340	$8.40	Acquired	2886461	Indirect
2025-05-06	Common Stock	P	10104	$8.64	Acquired	2896565	Indirect
2025-05-07	Common Stock	P	2703	$8.40	Acquired	2899268	Indirect
2025-05-07	Common Stock	P	9614	$8.64	Acquired	2908882	Indirect
2025-05-08	Common Stock	P	50	$8.65	Acquired	2908932	Indirect
2025-05-08	Common Stock	P	100	$8.65	Acquired	2909032	Indirect
2025-05-08	Common Stock	P	100	$8.65	Acquired	2909132	Indirect
2025-05-08	Common Stock	P	2400	$8.65	Acquired	2911532	Indirect

F1: Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.